1. Home
  2. EOLS vs DDL Comparison

EOLS vs DDL Comparison

Compare EOLS & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • DDL
  • Stock Information
  • Founded
  • EOLS 2012
  • DDL 2014
  • Country
  • EOLS United States
  • DDL China
  • Employees
  • EOLS N/A
  • DDL N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • DDL Catalog/Specialty Distribution
  • Sector
  • EOLS Health Care
  • DDL Consumer Discretionary
  • Exchange
  • EOLS Nasdaq
  • DDL Nasdaq
  • Market Cap
  • EOLS 493.5M
  • DDL 446.5M
  • IPO Year
  • EOLS 2018
  • DDL 2021
  • Fundamental
  • Price
  • EOLS $7.19
  • DDL $2.20
  • Analyst Decision
  • EOLS Strong Buy
  • DDL
  • Analyst Count
  • EOLS 5
  • DDL 0
  • Target Price
  • EOLS $21.25
  • DDL N/A
  • AVG Volume (30 Days)
  • EOLS 899.1K
  • DDL 677.3K
  • Earning Date
  • EOLS 11-05-2025
  • DDL 11-05-2025
  • Dividend Yield
  • EOLS N/A
  • DDL N/A
  • EPS Growth
  • EOLS N/A
  • DDL 372.99
  • EPS
  • EOLS N/A
  • DDL 0.21
  • Revenue
  • EOLS $277,941,000.00
  • DDL $3,335,962,059.00
  • Revenue This Year
  • EOLS $14.01
  • DDL $8.90
  • Revenue Next Year
  • EOLS $29.46
  • DDL $11.39
  • P/E Ratio
  • EOLS N/A
  • DDL $10.63
  • Revenue Growth
  • EOLS 17.15
  • DDL 15.14
  • 52 Week Low
  • EOLS $5.71
  • DDL $1.95
  • 52 Week High
  • EOLS $17.82
  • DDL $4.79
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 42.33
  • DDL 51.20
  • Support Level
  • EOLS $7.19
  • DDL $2.13
  • Resistance Level
  • EOLS $7.75
  • DDL $2.28
  • Average True Range (ATR)
  • EOLS 0.31
  • DDL 0.09
  • MACD
  • EOLS 0.05
  • DDL 0.01
  • Stochastic Oscillator
  • EOLS 0.65
  • DDL 60.00

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: